Methods Of Preventing Toxicity Of Platinum Drugs

  • Published: Feb 6, 2019
  • Earliest Priority: Jul 16 2015
  • Family: 7
  • Cited Works: 7
  • Cited by: 0
  • Cites: 3
  • Additional Info: Cited Works
Full-text?

The full document isn't yet available to us from the patent office, but we've found a related patent (family member) to use for our images and PDF.

Abstract

Methods for reducing platinum drug-induced toxicity in a cell expressing Organic Cation Transporter 2 (OCT2), methods for reducing platinum drug-induced toxicity in a subject, methods for treating cancer, methods for increasing efficacy of platinum drug treatment in a subject, and pharmaceutical compositions are described. The described methods and compositions include an OCT2 inhibitor where the OCT2 inhibitor is buflomedil or a salt thereof, dolutegravir or a salt thereof contains an imidazole, or is miconazole or a salt thereof.


Claims

Information currently unavailable.

Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Feb 6, 2019
  • Application: Jul 15, 2016
    EP EP 16825297 A
  • Priority: Jul 15, 2016
    US US 2016/0042673 W
  • Priority: Jul 16, 2015
    US US 201562193529 P

Download Citation


Sign in to the Lens

Feedback